Brean Murray Carret & Co Revises EPS Estimates Of Gilead

BenzingaStaffB , Benzinga Staff Writer

August 11, 2011 8:53am Comments

According to Brean, Gilead Sciences (NASDAQ: GILD), EPS estimates have changed.

Brean reported a change in EPS estimates from $3.91 to $3.65 for FY11 and from $4.40 to $4.22 for FY12. Rating is set to Buy with a PT of $52.

Gilead closed yesterday at $35.34.

Posted-In: Brean Murray Carret & Co Analyst Color Analyst Ratings

Need analyst data?
Click here to see licensing options.

Stock	Firm	Action	PT
SEDG	B of A Securities	Maintains	411.0
PTLO	Piper Sandler	Maintains	28.0
AOUT	Lake Street	Maintains	26.0
RAPT	Piper Sandler	Maintains	52.0
OCX	Lake Street	Maintains	6.0

1	GLD, VOO: Fed Skips Rate Cut Again—But Reveals Something We Haven't Seen Si...
2	UNH: UnitedHealth Hit By $6.5 Billion Medical Cost Blowout: Launches AI-Le...
3	AMZN, CAR: Dow Falls Over 150 Points After Powell's Comments On Ra...
4	$BTC, PI: Stock Market Today: S&P 500, Nasdaq To Open High...
5	UUP: Trump's Inflation Honeymoon Is Over—And Po...
6	QQQ, XLC: Meta's AI Firepower Could Ignite Mag...
7	TSLA: Ross Gerber Calls Tesla's Q2 Rep...

1	How A $25K Car Crash Settlement Could Leave This Mom Without SSI For Years
2	APO: If You Invested $1000 In This Stock 10 Years Ago, You Would Have This Much Today
3	PSTG: Here's How Much $1000 Invested In Pure Storage 5 Years Ago Would Be...
4	IGF, IDGT: BlackRock's New ETF BILT Bets On $68 Trillion Boom, But Mos...
5	The Return Fraud Epidemic: How $103 Billion In Returns Are Costi...
6	USFD: Here's How Much You Would Have Made Owning US Foods Hld...
7	CTSH, CLX: Clorox Claims Cognizant Handed Credentials To Hacke...

Market Overview